To evaluate a new implantable device, the Watchman FLX in patients with non-valvular atrial fibrillation who have an increased stroke risk.
|Eligibility criteria|| |
To be considered for the study you must meet the following criteria:
|Study details|| |
Your participation in this study would be for approximately 3 years.
You will need to attend the clinic for an initial assessment, including medical and medication history, physical examination, blood tests, echocardiogram and completing questionnaires regarding quality of life.
You will then be randomized 1:1 to receive either the device implantation or oral anticoagulants. You will be followed up in clinic at 3, 12, 24 and 36 months, where you will again be asked about your health and medications, have a physical examination and asked to complete questionnaires about your quality of life. For participants randomised to an implantable device, a transoesophageal echo will also be performed at 3 and 12 months
You will be reimbursed for any study-related travel and expenses.
Sign up to this clinical trial here.